INVOLVEMENT OF 5-HYDROXYTRYPTAMINE AND DOPAMINE IN BEHAVIORAL-EFFECTS OF ALPHA-METHYLTRYPTAMINE

被引：0

|

作者：

MARSDEN, CA

机构：

来源：

BRITISH JOURNAL OF PHARMACOLOGY | 1978年 / 64卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：P431 / P431

页数：1

相关论文

共 50 条

[1] EVIDENCE FOR THE RELEASE OF HIPPOCAMPAL 5-HYDROXYTRYPTAMINE BY ALPHA-METHYLTRYPTAMINE
MARSDEN, CA
BRITISH JOURNAL OF PHARMACOLOGY, 1979, 67 (03) : P438 - P439
[2] INVOLVEMENT OF 5-HYDROXYTRYPTAMINE AND DOPAMINE NEURONS IN THE BEHAVIORAL-EFFECTS OF ALPHA-METHYLYTRYPTAMINE
MARSDEN, CA
NEUROPHARMACOLOGY, 1980, 19 (08) : 691 - 698
[3] BEHAVIORAL-EFFECTS OF DOPAMINE AND 5-HYDROXYTRYPTAMINE IN CENTRALLY CHEMO-SYMPATHECTOMIZED RATS
HERMAN, ZS
BRUS, R
SZKILNIK, R
POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY, 1976, 28 (05): : 463 - 467
[4] BEHAVIORAL-EFFECTS OF PARACHLOROPHENYLALANINE - INHIBITOR OF 5-HYDROXYTRYPTAMINE SYNTHESIS
MCQUEEN, AE
LOUIS, WJ
SINGER, G
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1975, 2 (05) : 440 - 440
[5] CENTRAL EFFECTS AND METABOLISM OF ALPHA-METHYLTRYPTAMINE
KALIR, A
SZARA, S
FEDERATION PROCEEDINGS, 1962, 21 (02) : 337 - &
[6] BEHAVIORAL-EFFECTS OF ACUTE AND CHRONIC BETA-PHENYLETHYLAMINE ADMINISTRATION IN THE RAT - EVIDENCE FOR THE INVOLVEMENT OF 5-HYDROXYTRYPTAMINE
DOURISH, CT
NEUROPHARMACOLOGY, 1981, 20 (11) : 1067 - 1072
[7] BEHAVIORAL-EFFECTS OF 5,7-DIHYDROXYTRYPTAMINE LESIONS OF ASCENDING 5-HYDROXYTRYPTAMINE PATHWAYS
HOLE, K
FUXE, K
JONSSON, G
BRAIN RESEARCH, 1976, 107 (02) : 385 - 399
[8] HYMENOLEPIS-DIMINUTA - BEHAVIORAL-EFFECTS OF 5-HYDROXYTRYPTAMINE, ACETYLCHOLINE, HISTAMINE AND SOMATOSTATIN
SUKHDEO, MVK
HSU, SC
THOMPSON, CS
METTRICK, DF
JOURNAL OF PARASITOLOGY, 1984, 70 (05) : 682 - 688
[9] EFFECTS IN NORMAL MAN OF ALPHA-METHYLTRYPTAMINE AND ALPHA-ETHYLTRYPTAMINE
MURPHREE, HB
JENNEY, EH
DIPPY, RH
PFEIFFER, CC
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1961, 2 (06) : 722 - &
[10] SIMILAR BEHAVIORAL-EFFECTS OF 5-HYDROXYTRYPTAMINE AND SUBSTANCE-P INJECTED INTRATHECALLY IN MICE
FASMER, OB
BERGE, OG
HOLE, K
NEUROPHARMACOLOGY, 1983, 22 (04) : 485 - 487

← 1 2 3 4 5 →